How IBM Watson Is Being Used To Create Treatment Plans For Cancer Patients

How IBM Watson Is Being Used To Create Treatment Plans For Cancer Patients
Health

New data demonstrates the supercomputer's ability to assist doctors in treating cancer

Matt Vitone
  • 1 june 2017

IBM revealed this week how it’s Jeopardy-winning supercomputer Watson is being used for innovative healthcare applications. During a presentation at the American Society of Clinical Oncology’s annual meeting, the company presented new data that shows IBM Watson for Oncology is getting very good at recommending treatments for a variety of different cancers.

Utilizing Watson data from health centers around the world, IBM was interested to see how well Watson for Oncology was able to make the same treatment conclusions as a multi-disciplinary tumor board. Based on research done in India, it was found that Watson’s treatment recommendations matched those of doctors at a rate of 96 percent for lung, 81 percent for colon and 93 percent for rectal cancer cases. A different study in Thailand showed similar rates of concordance, according to IBM.

Watson is not only being used by doctors as a tool to make the best treatment choices for patients, but is also cutting down on the time it takes to screen for certain cancers for clinical trials. Using natural language processing capabilities, Watson CTM (Clinical Trials Matching) evaluated data from patient records and doctors notes against the protocols’ inclusion and exclusion criteria to automatically exclude ineligible patients: 94 percent of patients overall. This reduced clinical trial screening time from 1 hour and 50 minutes to just 24 minutes.

“These studies demonstrate that Watson technologies are doing what we expect them to do: helping physicians augment their own experience and expertise to deliver evidence-based care,” said Andrew Norden, deputy chief health officer for oncology and genomics at IBM Watson Health.

“As adoption of the technology grows globally, we are building on a growing body of data and evidence showing the value of Watson in cancer care,” he continued.

IBM Watson for Oncology was trained by leading doctors at New York’s Memorial Sloan Kettering Cancer Center. Using patient records, it can suggest certain treatment options based on the latest available medical research, helping keep doctors and patients up-to-date with cutting-edge treatment options.

In addition to treatments for breast, lung, colorectal, cervical, ovarian, and gastric cancers, IBM also announced this week that Watson for Oncology is now available to support the multi-disciplinary care of prostate cancer patients. By the end of the year, the technology will be available to support at least 12 cancer types, representing 80 percent of the global incidence of cancer.

IBM

IBM revealed this week how it’s Jeopardy-winning supercomputer Watson is being used for innovative healthcare applications. During a presentation at the American Society of Clinical Oncology’s annual meeting, the company presented new data that shows IBM Watson for Oncology is getting very good at recommending treatments for a variety of different cancers.

+AI
+artificial inteligence
+cancer
+cancer treatment
+Health
+Healthcare
+IBM
+IBM Watson
+Public
+Watson

Learn About Our Membership Services

Need Research Help?
As a member you can ask us any research questions and get complimentary research assistance with a 4-day turnaround. Reports inclde stats, quotes, and best-inclass examples on research topics.
Remain Informed & Strategic
We publish several trends reports each month. By becoming a member you will have access to over 100 existing reports, plus a growing catalog of deep topical analysis and debrief-style reports so you always remain in the know.
See Trends Come To Life
Meet your peers and immerse yourself in monthly trend and innovation webinars and discounted conferences.
No search results found.